Investigation of anticancer potential of hypophyllanthin and phyllanthin against breast cancer by in vitro and in vivo methods

Asian Pacific Journal of Tropical Disease

Volumn 4, Issue S1, 2014, Pages

  Parvathaneni, Madhukiran ^a   Battu, Ganga Rao ^a   Gray, Alexander I ^b   Gummalla, Pitchaiah ^a  

^a ANDHRA UNIVERSITY   (India)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Breast cancer; Hypophyllanthin; Phyllanthin; Phyllanthus amarus

Indexed keywords

ANTINEOPLASTIC AGENT; HYPOPHYLLANTHIN; LIGNAN DERIVATIVE; PHYLLANTHIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHYLLANTHUS AMARUS; PRIORITY JOURNAL; RAT;

EID: 84893491786     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(14)60417-5     Document Type: Article

References (32)

1. Patel JR, Tripathi P, Sharma V, Chauhan NS, Dixit VK Phyllanthus amarus ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmcol 2011, 138:286-313.
2. Huang RL, Huang YL, Ou JC, Chen CC, Hsu FL, Chang C Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phytother Res 2003, 17:449-453.
3. Kassuya CA, Leite DF, de Melo LV, Rehder VL, Calixto JB Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus. Planta Med 2005, 71:721-726.
4. Singh M, Tiwari N, Shanker K, Verma RK, Gupta AK, Gupta MM Two new lignans from Phyllanthus amarus. J Asian Nat Prod Res 2009, 11:562-568.
5. Srivastava V, Singh M, Malasoni R, Shanker K, Verma RK, Gupta MM, et al. Separation and quantification of lignans in Phyllanthus species by a simple chiral densitometric method. J Sep Sci 2008, 31:47-55.
6. Foo LY Amarulone a novel cyclic hydrolyzable tannin from Phyllanthus amarus. Nat Prod Lett 1993, 3:45-52.
7. Foo LY Amariinic acid and related ellagitannins from Phyllanthus amarus. Phytochemistry 1995, 39:217-224.
8. Maciel MAM, Cunha A, Dantas FTNC, Kaiser CR NMR characterization of bioactive lignans from Phyllanthus amarus Schum & Thonn. Ann Magn Reson 2007, 6:76-82.
9. Moronkola DO, Ogunwande IA, Oyewole IO, Baser KHC, Ozek T, Ozek G Studies on the volatile oils of Momordica charantia L. (Cucurbitaceae) and Phyllanthus amarus Sch. & Thonn (Euphorbiaceae). J Essent Oil Res 2009, 21:393-399.
10. Igwe CU, Nwaogu LA, Ujuwondu CO Assessment of the hepatic effects, phytochemical and proximate compositions of Phyllanthus amarus. Afr J Biotechnol 2007, 6:728-731.
11. Surya Narayanan B, Latha P, Rukkumani R Protective effects of Phyllanthus amarus on fibrotic markers during alcohol and polyunsaturated fatty acid-induced toxicity. Toxicol Mech Methods 2011, 21:48-52.
12. Cartaxo SL, Souza MM, de Albuquerque UP Medicinal plants with bioprospecting potential used in semi-arid northeastern Brazil. J Ethnopharmacol 2010, 131:326-342.
13. Kumar KBH, Kuttan R Inhibition of drug metabolizing enzymes (cytochrome P450) in vitro as well as in vivo by Phyllanthus amarus Schum & Thonn. Biol Pharm Bull 2006, 29:1310-1313.
14. Raphael KR, Sabu M, Kumar KH, Kuttan R Inhibition of N-Methyl N'-nitro-N-nitrosoguanidine (MNNG) induced gastric carcinogenesis by Phyllanthus amarus extract. Asian Pac J Cancer Prev 2006, 7:299-302.
15. Ravikumar YS, Ray U, Nandhitha M, Perween A, Raja Naika H, Khanna N, et al. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res 2011, 158:89-97.
16. Notka F, Meier G, Wagner R Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res 2004, 64:93-102.
17. Leite DF, Kassuya CA, Mazzuco TL, Silvestre A, de Melo LV, Rehder VL, et al. The cytotoxic effect and the multidrug resistance reversing action of lignans from Phyllanthus amarus. Planta Med 2006, 72:1353-1358.
18. Chirdchupunseree H, Pramyothin P Protective activity of phyllanthin in ethanol-treated primary culture of rat hepatocytes. J Ethnopharmacol 2010, 128:172-176.
19. 4-induced toxicity in HepG2 cell line. Chem Biol Interact 2009, 181:351-358.
20. Rao BG, Kiran PM, Kumar JR In vitro antioxidant activity of different extracts and isolated lignans of Phyllanthus amarus Schum. & Thonn. aerial parts. Inventi Rapid: Planta Activa 2013, (1):1-3.
21. Kiran PM, Rao BG Evaluation of anti-inflammatory activity of different extracts and isolated lignans of Phyllanthus amarus Schum. & Thonn. aerial parts. Int J Pharm Bio Sci 2013, 4:803-808.
22. Anjaneyulu ASR, Rao KJ, Row LR, Subrahmanyam C Crystalline constituents of Euphorbiaceae-XII: Isolation and structural elucidation of three new lignans from the leaves of Phyllanthus niruri. Tetrahedron 1973, 2:1291-1298.
23. Waheed A, Bibi Y, Nisa S, Chaudhary FM, Sahreen S, Zia M Inhibition of human breast and colorectal cancer cells by Viburnum foetens L. extracts in vitro. Asian Pac J Trop Dis 2013, 3:32-36.
24. Ravikumar S, Fredimoses M, Gnanadesigan M Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines. Asian Pac J Trop Biomed 2012, 2:92-96.
25. Gotoh T, Yamada K, Ito A, Yin H, Kataoka T, Dohi K Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination. Jpn J Cancer Res 1998, 89:487-495.
26. McCormick DL, Becci PJ, Moon RC Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2). Carcinogenesis 1982, 3:1473-1476.
27. Jagatheesh K, Arumugam V, Elangovan N, Pavan Kumar P Evaluation of the anti-tumor and antioxidant activity of Amorphophallus paeonifolius on DMBA induced mammary carcinoma. Int J Chem Pharm Sci 2010, 1:40-49.
28. Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 2005, 7:291-295.
29. Angelopoulos N, Barbounis V, Livadas S, Kaltsas D, Tolis G Effects of estrogen deprivation due to breast cancer treatment. Endocr Relat Cancer 2004, 11:523-535.
30. Jo EH, Hong HD, Ahn NC, Jung JW, Yang SR, Park JS, et al. Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J Agric Food Chem 2004, 52:1715-1719.
31. Ivanova D, Gerova D, Chervenkov T, Yankova T Polyphenols and antioxidant capacity of Bulgarian medicinal plants. J Ethnopharmacol 2005, 96:145-150.
32. Adlercreutz H, Fotsis T, Heikkinen R, Dwyer JT, Woods M, Goldin BR, et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982, 2:1295-1299.